Margaret Edison

843 total citations
10 papers, 669 citations indexed

About

Margaret Edison is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Margaret Edison has authored 10 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Margaret Edison's work include Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Margaret Edison is often cited by papers focused on Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Margaret Edison collaborates with scholars based in United States and Ukraine. Margaret Edison's co-authors include Daniel C. Ihde, Ruby Phelps, James L. Mulshine, R. Ilona Linnoila, Adi F. Gazdar, May Lesar, Bruce E. Johnson, S. M. Steinberg, Eli Glatstein and Allen S. Lichter and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and CHEST Journal.

In The Last Decade

Margaret Edison

10 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Edison United States 8 563 437 284 225 29 10 669
Charles S. Faulkner United States 6 337 0.6× 267 0.6× 188 0.7× 119 0.5× 16 0.6× 12 443
Masayuki Nishioka Japan 6 374 0.7× 243 0.6× 359 1.3× 331 1.5× 64 2.2× 16 732
Astrid Keijser Netherlands 6 479 0.9× 342 0.8× 273 1.0× 102 0.5× 22 0.8× 11 570
Mirjana Wollner Israel 4 515 0.9× 329 0.8× 295 1.0× 141 0.6× 149 5.1× 5 696
H Karnicka-Młodkowska Poland 9 391 0.7× 225 0.5× 202 0.7× 99 0.4× 11 0.4× 24 464
Adityanarayan Bhatnagar United Kingdom 3 336 0.6× 245 0.6× 197 0.7× 69 0.3× 21 0.7× 3 382
Nicole H. Gower United Kingdom 7 208 0.4× 129 0.3× 385 1.4× 67 0.3× 41 1.4× 13 487
Denise Stys‐Norman Canada 8 182 0.3× 65 0.1× 205 0.7× 86 0.4× 28 1.0× 9 331
Haruhito Kamei Japan 9 389 0.7× 53 0.1× 465 1.6× 53 0.2× 32 1.1× 37 573
Ignazio Cataldo Italy 11 225 0.4× 117 0.3× 199 0.7× 106 0.5× 42 1.4× 48 443

Countries citing papers authored by Margaret Edison

Since Specialization
Citations

This map shows the geographic impact of Margaret Edison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Edison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Edison more than expected).

Fields of papers citing papers by Margaret Edison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Edison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Edison. The network helps show where Margaret Edison may publish in the future.

Co-authorship network of co-authors of Margaret Edison

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Edison. A scholar is included among the top collaborators of Margaret Edison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Edison. Margaret Edison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Breathnach, Oscar S., Vijay Kasturi, Frederic J. Kaye, et al.. (2002). Phase II Neoadjuvant Trial of Paclitaxel by 96-Hour Continuous Infusion (CIVI) in Combination With Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 25(3). 269–273. 2 indexed citations
2.
Lesar, May, et al.. (1997). Obstructive Atelectasis in Patients With Small Cell Lung Cancer. CHEST Journal. 111(1). 115–120. 31 indexed citations
3.
Johnson, Bruce E., J. R. Gray, R. Ilona Linnoila, et al.. (1996). Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.. Journal of Clinical Oncology. 14(3). 806–813. 97 indexed citations
4.
Ihde, Daniel C., James L. Mulshine, B S Kramer, et al.. (1994). Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.. Journal of Clinical Oncology. 12(10). 2022–2034. 194 indexed citations
5.
Johnson, Bruce E., Adi F. Gazdar, May Lesar, et al.. (1993). Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer. 9. S21–S26. 19 indexed citations
6.
Dmitrovsky, Ethan, E Seifter, Adi F. Gazdar, et al.. (1990). A Phase II Trial of Carboplatin (CBDCA) in Small-Cell and Non-Small-Cell Lung Cancer with Correlation to In Vitro Analysis of Cytotoxicity. American Journal of Clinical Oncology. 13(4). 285–289. 5 indexed citations
7.
Johnson, Barry C., Shannon M. Steinberg, Ruby Phelps, et al.. (1988). Female patients with small cell lung cancer live longer than male patients1. The American Journal of Medicine. 85. 194–196. 7 indexed citations
8.
Johnson, Bruce E., et al.. (1988). Female patients with small cell lung cancer live longer than male patients. The American Journal of Medicine. 85(2). 194–196. 75 indexed citations
9.
Bunn, P. A., Allen S. Lichter, Robert Makuch, et al.. (1987). Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer. Annals of Internal Medicine. 106(5). 655–662. 182 indexed citations
10.
Brooks, Burke J., E Seifter, Thomas Walsh, et al.. (1986). Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.. Journal of Clinical Oncology. 4(2). 200–209. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles S. Faulkner Breakdown of academic impact, for papers by Masayuki Nishioka Breakdown of academic impact, for papers by Astrid Keijser Breakdown of academic impact, for papers by Mirjana Wollner Breakdown of academic impact, for papers by H Karnicka-Młodkowska Breakdown of academic impact, for papers by Adityanarayan Bhatnagar Breakdown of academic impact, for papers by Nicole H. Gower Breakdown of academic impact, for papers by Denise Stys‐Norman Breakdown of academic impact, for papers by Haruhito Kamei Breakdown of academic impact, for papers by Ignazio Cataldo
Rankless by CCL
2026